Onychomycosis of Toenail
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
VP
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
Axiom2.4% Topical Terbinafine
Vanda PharmaceuticalsTrichostatin A
Clinical Trials (2)
Total enrollment: 50 patients across 2 trials
A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails
Start: Mar 2026Est. completion: Feb 2028
Phase 2Not Yet Recruiting
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
Start: May 2025Est. completion: Sep 202650 patients
Phase 2Active Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space